Di(Hydroxyethyl)Ether

Di(Hydroxyethyl)Ether

SCHEMBL273879

CCCOC.OCCOCCO

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.59
MAPK1 P28482 2/20 0.56
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 3/20 0.52
THRB P10828 1/20 0.52
HTT P42858 1/20 0.52
MAPT P10636 1/20 0.52
USP2 O75604 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 2/20 0.34
LMNA P02545 1/20 0.34
CASP1 P29466 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
HSD17B10 Q99714 1/20 0.33
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL274347 0.97 MEN1 (0.58) TSHRMAPK1MEN1KMT2AALDH1A1
Hexaethylene Glycol SCHEMBL11969805 0.97 MEN1 (0.58) TSHRMAPK1MEN1KMT2AALDH1A1
Pentaethylene Glycol SCHEMBL11969961 0.97 MEN1 (0.58) TSHRMAPK1MEN1KMT2AALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL22393242 0.97 TSHR (0.56) TSHRMAPK1MEN1KMT2AALDH1A1
Tetraethylene Glycol SCHEMBL11969914 0.97 MEN1 (0.58) TSHRMAPK1MEN1KMT2AALDH1A1
2-Methoxyethanol SCHEMBL28071905 0.92 TSHR (0.56) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL5924573 0.90 MEN1 (0.55) TSHRMAPK1MEN1KMT2AALDH1A1
Propanol SCHEMBL22393243 0.86 MEN1 (0.58) TSHRMAPK1MEN1KMT2AALDH1A1
Methoxymethane SCHEMBL10800859 0.86 TSHR (0.62) TSHRMAPK1MEN1KMT2AALDH1A1
Hydroxyl Radical SCHEMBL28289861 0.86 MEN1 (0.65) TSHRMAPK1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025094814-A1 DETERGENT COMPOSITION AND RECYCLING SYSTEM 東ソー株式会社 2025-05-08 WO claimed
CN-111373318-B Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element 日产化学株式会社 2023-06-09 CN claimed
US-11573490-B2 Positive-type photosensitive resin composition and cured film prepared therefrom ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-02-07 US claimed
CN-217724629-U A recovery cauldron for diethylene glycol methyl propyl ether 安徽立兴新材料有限公司 2022-11-04 CN claimed
CN-105385457-B Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element JSR株式会社 2021-03-30 CN claimed
US-20200409266-A1 POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM PREPARED THEREFROM DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2020-12-31 US claimed
CN-112147845-A Positive photosensitive resin composition and cured film prepared therefrom 罗门哈斯电子材料韩国有限公司 2020-12-29 CN claimed
CN-107077031-B Liquid crystal aligning agent containing polyamic acid or derivative thereof, liquid crystal alignment film, and liquid crystal display element JNC株式会社 2020-11-06 CN claimed
CN-111373318-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学株式会社 2020-07-03 CN claimed
CN-105385457-A Liquid crystal orientation agent, liquid crystal orientation film and liquid crystal display element JSR CORP 2016-03-09 CN claimed
US-12633572-B2 Electrolytic solution and electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-05-19 US disclosed
US-12630731-B2 Non-aqueous ink composition DNP FINE CHEMICALS CO., LTD. (JP) 2026-05-19 US disclosed
US-20260125570-A1 NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS DNP FINE CHEMICALS CO., LTD. (JP) 2026-05-07 US disclosed
US-12597635-B2 Electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-04-07 US disclosed
US-12577401-B2 Curable resin composition, cured film formed therefrom, and electronic device having cured film SAMSUNG SDI CO., LTD. (KR) 2026-03-17 US disclosed
EP-0464652-B1 Agent and method for removing rosin-base solder flux ARAKAWA CHEM IND (JP) 1995-09-20 EP disclosed
US-5330582-A Using mixture og glycol ether and nonionic surfactants ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-19 US disclosed
US-5256209-A Using mixture of glycol ether, nonionic surfactant, anionic phosphate surfactant ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 1993-10-26 US disclosed
EP-0464652-A1 Agent and method for removing rosin-base solder flux ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 1992-01-08 EP disclosed
US-4176132-A Reaction of organic diisocyanates with water ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1979-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630731-B2 Non-aqueous ink composition EXOSC10, RPP30, RPS20 TSHR 2930/4885MAPK1 3064/4885MEN1 2255/4885
US-12633572-B2 Electrolytic solution and electrochemical device KCNN1, HCN4, KCNN2 TSHR 312/4885MAPK1 372/4885MEN1 801/4885
US-12597635-B2 Electrochemical device CLCN2, HCN4, SLC26A3 TSHR 1300/4885MAPK1 1413/4885MEN1 1871/4885
US-12577401-B2 Curable resin composition, cured film formed therefrom, and electronic device having cured film SEM1, CARM1, CAD TSHR 4032/4885MAPK1 4403/4885MEN1 3007/4885
US-20260125570-A1 NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS BMI1, IK, PRDM9 TSHR 4439/4885MAPK1 2018/4885MEN1 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.